As part of their fight against the opioid crisis, the US Food and Drug Administration and the Drug Enforcement Administration have issued joint warning letters to several website operators illegally marketing and selling opioids
.
On Monday, the FDA and DEA announced that they sent warnings to four online networks, operating a total of 10 websites, which the agencies said are illegally marketing unapproved and misbranded versions of opioid medicines, including tramadol.These warning letters come just months after the FDA issued a similar series of warnings to other opioid-selling website operators.'use strict';CNN.Videx=CNN.Videx || {};CNN.Videx.mobile={};CNN.INJECTOR.executeFeature.then {CNN.VideoPlayer.
Emails show drug execs indifferent to opioid epidemic 02:04The online networks that received the new warning letters, sent earlier this month, are Divyata, Euphoria Healthcare Pvt Ltd., JCM Dropship and Meds4U. None of the companies immediately responded to CNN's requests for comment.The letters call for the website operators to immediately stop illegally selling the opioids to consumers in the United States.
In April, warning letters were issued to azmedicinalshop.com and thedonrx.net to cease offering violative drugs for sale to consumers in the United States. Warning letters were also sent to dozens of websites last year on two separate occasions.Also last year, Mark Zuckerberg took heat from members of Congress over illegal opioid sales on Facebook -- and the issue isn't exactly new.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Narco-Submarine Interdicted By U.S. Coast Guard: What’s Interesting About This Drug-Smuggling VesselThe narco-sub phenomenon is on the increase, and a stealthy vessel captured recently by the U.S. Coast Guard is an example of the standardization of the designs.
Read more »
Zantac cancer warning: Why CVS is recalling heartburn drug and what alternative medication you can take'CVS Pharmacy has suspended the sale of all Zantac brand and CVS Health brand ranitidine products until further notice,' a spokesperson for the brand wrote in a press release.
Read more »
Can Washington deliver on drug costs amid impeachment probe?Major legislation to reduce prescription drug costs for millions of people may get sidelined now that House Democrats have begun an impeachment inquiry of Pres. Trump.
Read more »
'Revolutionary' drug for prostate cancerOlaparib could be a 'transformative' treatment for thousands of men with advanced prostate cancer, say experts.
Read more »